Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Zivo Bioscience's price to sales ratio was 124.7× on Oct 19, 2026, against 305.5× a year earlier. Over the last 2 years it ranged from 60.5× to 465.2×, with a median of 192.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 124.7× | −34.8 |
| 2025 | Dec 31, 2025 | 159.5× | −214.7 |
| 2024 | Jul 31, 2024 | 374.2× | +242.3 |
| 2023 | Dec 29, 2023 | 131.9× | – |
See a number that looks wrong?